Vanguard Group Inc Neuroone Medical Technologies Corp Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Vanguard Group Inc holds 1,110,690 shares of NMTC stock, worth $677,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,110,690

Previous 919,528 20.79%

Holding current value

$677,520

Previous $754,000 25.2%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.83 - $1.22 $158,664 - $233,217	191,162 Added 20.79%	1,110,690 $944,000
Q2 2024 Aug 13, 2024	BUY	$0.68 - $1.27 $140 - $262	207 Added 0.02%	919,528 $735,000
Q1 2024 May 10, 2024	BUY	$1.03 - $1.62 $1,741 - $2,739	1,691 Added 0.18%	919,321 $1.1 Million
Q4 2023 Feb 14, 2024	BUY	$0.86 - $1.92 $411,208 - $918,046	478,149 Added 108.8%	917,630 $1.45 Million
Q3 2023 Nov 14, 2023	SELL	$0.85 - $1.99 $656 - $1,536	-772 Reduced 0.18%	439,481 $391,000
Q2 2023 Aug 14, 2023	SELL	$1.01 - $1.88 $4,654 - $8,663	-4,608 Reduced 1.04%	440,253 $528,000
Q1 2023 May 15, 2023	BUY	$1.21 - $2.06 $429,787 - $731,703	355,196 Added 396.14%	444,861 $716,000
Q4 2022 Feb 10, 2023	BUY	$0.84 - $2.82 $5,667 - $19,026	6,747 Added 8.14%	89,665 $107,000
Q3 2022 Nov 14, 2022	SELL	$0.84 - $2.55 $131,437 - $399,006	-156,473 Reduced 65.36%	82,918 $141,000
Q1 2022 May 13, 2022	BUY	$1.1 - $2.96 $24,374 - $65,590	22,159 Added 10.2%	239,391 $264,000
Q4 2021 Feb 14, 2022	BUY	$1.9 - $4.13 $412,740 - $897,168	217,232 New	217,232 $421,000

Others Institutions Holding NMTC

# of Institutions

Shares Held

1.93M

Call Options Held

69.6K

Put Options Held

View Full List

About NEUROONE MEDICAL TECHNOLOGIES Corp

Ticker NMTC
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 16,209,200
Market Cap $9.89M
Description
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...

More about NMTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Neuroone Medical Technologies Corp Transaction History